Circulating Tumor DNA in Hepatocellular Carcinoma: Current Status and Emerging Role in Treatment Monitoring
Hepatocellular carcinoma (HCC) remains a major global health challenge, characterized by high incidence, late diagnosis, and frequent recurrence despite curative-intent treatments.
















